Why some people with normal pressure hydrocephalus do not improve after shunt surgery
Studies brain nerve pathways and dementia markers in older adults with normal pressure hydrocephalus.
Key facts
- Who runs it
- Imperial College London
- Where
- London, United KingdomSee the site
- Trial code
- Registry title
- White Matter Distortion and Dementia Biomarkers in Normal Pressure Hydrocephalus (NPH)
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 25 Mar 2025
- Expected to end
- Feb 2029
- Type of study
- Observational, 2 groups
- Treatments tested
- Ventriculoperitoneal Shunt (VP)
- Brain and Skin Biopsy
- MRI Brain
- Record updated
- 27 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults over 60 with normal pressure hydrocephalus (extra fluid in the brain) who may have shunt surgery. It also takes a comparison group: people with other dementias, hydrocephalus without symptoms, and healthy people.
- Age
- Group 1: over 60. Minimum age 60 Years.
- Sex
- All sexes can join.
- Disease stage
- Group 1: communicating hydrocephalus with walking problems (gait apraxia) and bladder problems, with or without memory or thinking problems. Group 2: healthy carers, members of the public, Imperial College/ICHT staff, people with non-NPH dementia (such as Alzheimer's disease or vascular dementia), or hydrocephalus without symptoms.
- Biomarker or test result
- Group 1: brain imaging with an Evan's index >0.3 and an iNPH Radscale score >4.
Main reasons for not taking part
- Group 1: high-pressure hydrocephalus, or hydrocephalus without symptoms
- Group 1: serious head injury within 5 years, or a clear other cause such as brain infection
- Group 1: another clear cause of symptoms, such as Parkinson's disease, nerve damage or a neck spinal cord problem
- Group 1: too frail for shunt surgery, medically unstable, unable to move, or unable to have an MRI or lumbar puncture
- Anyone unable to come to the hospital for study visits
The registry criteria, word for word
Show all 23 criteriaShow less
Who can take part
- Adult patients >60
- With gait apraxia
- With or without cognitive impairment
- Urinary dysfunction
- Communicating Hydrocephalus
- Healthy Carers
- Members of the Public
- Staff of Imperial College/ICHT
- Non-NPH Dementias (including Alzheimer's disease or vascular dementia)
- Asymptomatic Hydrocephalus
Who cannot take part
- Too frail for shunt surgery
- Serious head injury within 5 years of presentation or a clear secondary cause (e.g. brain infection)
- History of childhood gait disturbance
- Clear alternative explanation for symptoms (e.g. Parkinson's disease with limb rigidity, peripheral neuropathy with sensory ataxia, cervical myelopathy)
- Medically unstable (e.g. active angina, respiratory disease, recurrent delirium, active epilepsy)
- Unable to attend the hospital for study visits; Group 2 (asymptomatic and non-hydrocepahlus dementia and healthy controls):
- Asymptomatic hydrocephalus
- High pressure-hydrocephalus
- Unable to tolerate MRI brain imaging
- Unable to have a lumbar puncture
- Immobile
- Unable to attend the hospital for study visits
Other criteria
- Group 1 (communicating hydrocephalus):
Where in United Kingdom
- Imperial College Healthcare NHS TrustLondon, United KingdomContact: Chris Carswell, PHD, FRCPTaking people
About the trial
What the trial wants to find out
Idiopathic Normal Pressure Hydrocephalus (iNPH) is a progressive condition of the elderly that results in severe disability. iNPH can dramatically respond to Cerebral spinal fluid(CSF)-shunting where excess ventricular fluid is diverted from the brain. Not all patients with iNPH respond to CSF-shunting however. The reasons for this are uncertain.
Read full original descriptionShow less
Aim 1: To understand if specific nerve pathways (white matter tracts) that are near ventricles are damaged in patients that respond to shunting as opposed to those that do not.
Aim 2: Can we explain shunt non-responsiveness by screening for dementia like illnesses (neurodegeneration) using a large array of methods.
Aim 3: To understand whether wearable activity and bed sleep monitors are palatable in a NPH population and to understand if these metrics relate to quality of life.
Aim 4: To see whether self-administered digital cognitive assessments can measure improvements pre and post surgery.
The 2 groups in the trial
- Group 1
Group 1 includes adults over 60 years old diagnosed with late-onset communicating hydrocephalus, characterised by gait apraxia, with or without cognitive impairment and urinary dysfunction. Eligibility is confirmed through clinical imaging showing an Evan's index \>0.3 and an iNPH Radscale score \>4. Individuals with recent severe head trauma, high-pressure hydrocephalus, or alternative causes for similar symptoms are excluded. This criteria for group 1 ensures a distinct group for studying the late-onset, communicating form of the condition.
Treatment: Ventriculoperitoneal Shunt (VP), Brain and Skin Biopsy, and MRI Brain
- Group 2
Group 2 will include 30 adult patients with asymptomatic chronic hydrocephalus, non-hydrocephalus dementia and healthy controls.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Observational Study to Investigate the Effect of White Matter Tract Distortion and Neurodegenerative Biomarkers on Shunt-responsiveness in Idiopathic Normal Pressure Hydrocephalus (iNPH)
- Plain-language title
- Why some people with normal pressure hydrocephalus do not improve after shunt surgeryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 27 March 2026